Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-04 4:24 pm Sale | 2025-03-31 | 13G | Haemonetics Corporation HAE | Capital Research Global Investors | 1,577,323 3.100% | -2,865,330 (-64.50%) | Filing History |
| 2024-11-14 1:28 pm Purchase | 2024-09-30 | 13G | Haemonetics Corporation HAE | T. Rowe Price Investment Management, Inc. | 2,850,637 5.600% | 2,850,637 (New Position) | Filing History |
| 2024-11-12 12:54 pm Sale | 2024-11-07 | 13G | Haemonetics Corporation HAE | Capital Research Global Investors | 4,442,653 8.700% | -2,080,915 (-31.90%) | Filing History |
| 2024-11-08 10:41 am Purchase | 2024-09-30 | 13G | Haemonetics Corporation HAE | Wellington Management Group LLP | 4,230,850 8.270% | 962,767 (+29.46%) | Filing History |
| 2024-02-13 5:06 pm Purchase | 2023-12-29 | 13G | Haemonetics Corporation HAE | The Vanguard Group | 5,406,309 10.650% | 163,473 (+3.12%) | Filing History |
| 2024-02-13 3:28 pm Sale | 2023-12-31 | 13G | Haemonetics Corporation HAE | Neuberger Berman Group LLC | 3,531,181 6.960% | -342,255 (-8.84%) | Filing History |
| 2024-02-09 5:49 pm Purchase | 2024-02-07 | 13G | Haemonetics Corporation HAE | Capital Research Global Investors | 6,523,568 12.900% | 567,504 (+9.53%) | Filing History |
| 2024-02-08 10:21 am Sale | 2023-12-29 | 13G | Haemonetics Corporation HAE | Wellington Management Group LLP | 3,268,083 6.440% | -766,670 (-19.00%) | Filing History |
| 2024-01-23 4:13 pm Purchase | 2023-12-31 | 13G | Haemonetics Corporation HAE | BlackRock Inc. BLK | 6,056,881 11.900% | 158,261 (+2.68%) | Filing History |
| 2023-02-13 3:32 pm Purchase | 2023-02-14 | 13G | Haemonetics Corporation HAE | Capital Research Global Investors | 5,956,064 11.800% | 504,058 (+9.25%) | Filing History |
| 2023-02-10 2:10 pm Sale | 2022-12-31 | 13G | Haemonetics Corporation HAE | Neuberger Berman Group LLC | 3,873,436 7.650% | -3,085 (-0.08%) | Filing History |
| 2023-02-09 11:22 am Purchase | 2022-12-30 | 13G | Haemonetics Corporation HAE | The Vanguard Group | 5,242,836 10.360% | 47,641 (+0.92%) | Filing History |
| 2023-02-06 3:00 pm Sale | 2022-12-30 | 13G | Haemonetics Corporation HAE | Wellington Management Group LLP | 4,034,753 7.970% | -1,502,785 (-27.14%) | Filing History |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | Haemonetics Corporation HAE | BlackRock Inc. BLK | 5,898,620 11.700% | 0 (Unchanged) | Filing History |
| 2023-01-20 3:00 pm Sale | 2022-12-31 | 13G | Haemonetics Corporation HAE | BlackRock Inc. BLK | 5,898,620 11.700% | -793,726 (-11.86%) | Filing History |
| 2022-10-11 10:07 am Purchase | 2022-09-30 | 13G | Haemonetics Corporation HAE | The Vanguard Group | 5,195,195 10.120% | 314,259 (+6.44%) | Filing History |
| 2022-04-08 11:19 am Purchase | 2022-04-11 | 13G | Haemonetics Corporation HAE | Capital Research Global Investors | 5,452,006 10.700% | 3,402,873 (+166.06%) | Filing History |
| 2022-02-14 2:29 pm Purchase | 2021-12-31 | 13G | Haemonetics Corporation HAE | Neuberger Berman Group LLC | 3,876,521 7.590% | 1,043,472 (+36.83%) | Filing History |
| 2022-02-11 12:22 pm Sale | 2022-02-14 | 13G | Haemonetics Corporation HAE | Capital Research Global Investors | 2,049,133 4.000% | -726,503 (-26.17%) | Filing History |
| 2022-02-10 08:16 am Purchase | 2021-12-31 | 13G | Haemonetics Corporation HAE | The Vanguard Group | 4,880,936 9.550% | 28,654 (+0.59%) | Filing History |